Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model

Jeremy C. McIntyre, Erica E. Davis, Ariell Joiner, Corey L. Williams, I. Chun Tsai, Paul M. Jenkins, Dyke P. McEwen, Lian Zhang, John Escobado, Sophie Thomas, Katarzyna Szymanska, Colin A. Johnson, Philip L. Beales, Eric D. Green, James C. Mullikin, Aniko Sabo, Donna M. Muzny, Richard A. Gibbs, Tania Attié-Bitach, Bradley K. YoderRandall R Reed, Nicholas Katsanis, Jeffrey R. Martens

Research output: Contribution to journalArticle

Abstract

Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception. In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders. Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88 Tg737Rpw mice, also known as ORPK mice) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.

Original languageEnglish (US)
Pages (from-to)1423-1428
Number of pages6
JournalNature Medicine
Volume18
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Gene therapy
Cilia
Genetic Therapy
Defects
Neurons
Olfactory Receptor Neurons
Cell signaling
Organelles
Mutation
Pathology
Assays
Carrier Proteins
Genes
Inborn Genetic Diseases
Zebrafish
Microtubules
Cell Movement
Virulence
Therapeutics
Alleles

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

McIntyre, J. C., Davis, E. E., Joiner, A., Williams, C. L., Tsai, I. C., Jenkins, P. M., ... Martens, J. R. (2012). Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. Nature Medicine, 18(9), 1423-1428. https://doi.org/10.1038/nm.2860

Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. / McIntyre, Jeremy C.; Davis, Erica E.; Joiner, Ariell; Williams, Corey L.; Tsai, I. Chun; Jenkins, Paul M.; McEwen, Dyke P.; Zhang, Lian; Escobado, John; Thomas, Sophie; Szymanska, Katarzyna; Johnson, Colin A.; Beales, Philip L.; Green, Eric D.; Mullikin, James C.; Sabo, Aniko; Muzny, Donna M.; Gibbs, Richard A.; Attié-Bitach, Tania; Yoder, Bradley K.; Reed, Randall R; Katsanis, Nicholas; Martens, Jeffrey R.

In: Nature Medicine, Vol. 18, No. 9, 09.2012, p. 1423-1428.

Research output: Contribution to journalArticle

McIntyre, JC, Davis, EE, Joiner, A, Williams, CL, Tsai, IC, Jenkins, PM, McEwen, DP, Zhang, L, Escobado, J, Thomas, S, Szymanska, K, Johnson, CA, Beales, PL, Green, ED, Mullikin, JC, Sabo, A, Muzny, DM, Gibbs, RA, Attié-Bitach, T, Yoder, BK, Reed, RR, Katsanis, N & Martens, JR 2012, 'Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model', Nature Medicine, vol. 18, no. 9, pp. 1423-1428. https://doi.org/10.1038/nm.2860
McIntyre JC, Davis EE, Joiner A, Williams CL, Tsai IC, Jenkins PM et al. Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. Nature Medicine. 2012 Sep;18(9):1423-1428. https://doi.org/10.1038/nm.2860
McIntyre, Jeremy C. ; Davis, Erica E. ; Joiner, Ariell ; Williams, Corey L. ; Tsai, I. Chun ; Jenkins, Paul M. ; McEwen, Dyke P. ; Zhang, Lian ; Escobado, John ; Thomas, Sophie ; Szymanska, Katarzyna ; Johnson, Colin A. ; Beales, Philip L. ; Green, Eric D. ; Mullikin, James C. ; Sabo, Aniko ; Muzny, Donna M. ; Gibbs, Richard A. ; Attié-Bitach, Tania ; Yoder, Bradley K. ; Reed, Randall R ; Katsanis, Nicholas ; Martens, Jeffrey R. / Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. In: Nature Medicine. 2012 ; Vol. 18, No. 9. pp. 1423-1428.
@article{054c2c18051a4546854508adbe7815b6,
title = "Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model",
abstract = "Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception. In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders. Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88 Tg737Rpw mice, also known as ORPK mice) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.",
author = "McIntyre, {Jeremy C.} and Davis, {Erica E.} and Ariell Joiner and Williams, {Corey L.} and Tsai, {I. Chun} and Jenkins, {Paul M.} and McEwen, {Dyke P.} and Lian Zhang and John Escobado and Sophie Thomas and Katarzyna Szymanska and Johnson, {Colin A.} and Beales, {Philip L.} and Green, {Eric D.} and Mullikin, {James C.} and Aniko Sabo and Muzny, {Donna M.} and Gibbs, {Richard A.} and Tania Atti{\'e}-Bitach and Yoder, {Bradley K.} and Reed, {Randall R} and Nicholas Katsanis and Martens, {Jeffrey R.}",
year = "2012",
month = "9",
doi = "10.1038/nm.2860",
language = "English (US)",
volume = "18",
pages = "1423--1428",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model

AU - McIntyre, Jeremy C.

AU - Davis, Erica E.

AU - Joiner, Ariell

AU - Williams, Corey L.

AU - Tsai, I. Chun

AU - Jenkins, Paul M.

AU - McEwen, Dyke P.

AU - Zhang, Lian

AU - Escobado, John

AU - Thomas, Sophie

AU - Szymanska, Katarzyna

AU - Johnson, Colin A.

AU - Beales, Philip L.

AU - Green, Eric D.

AU - Mullikin, James C.

AU - Sabo, Aniko

AU - Muzny, Donna M.

AU - Gibbs, Richard A.

AU - Attié-Bitach, Tania

AU - Yoder, Bradley K.

AU - Reed, Randall R

AU - Katsanis, Nicholas

AU - Martens, Jeffrey R.

PY - 2012/9

Y1 - 2012/9

N2 - Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception. In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders. Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88 Tg737Rpw mice, also known as ORPK mice) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.

AB - Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception. In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders. Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88 Tg737Rpw mice, also known as ORPK mice) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.

UR - http://www.scopus.com/inward/record.url?scp=84868638709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868638709&partnerID=8YFLogxK

U2 - 10.1038/nm.2860

DO - 10.1038/nm.2860

M3 - Article

C2 - 22941275

AN - SCOPUS:84868638709

VL - 18

SP - 1423

EP - 1428

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -